|
| GSTT1 | GSTM1 | ||
| GSTT1 (+) | GSTT1 (del) | GSTM1 (+) | GSTM1 (del) | |
| Histology* | ||||
| squamous cell carcinoma | 67 (73.3%) | 24 (26.7%) | 39 (42.9%) | 52 (57.1%) |
| adenocarcinoma | 72 (87.8%) | 10 (12.2%) | 40 (49.8%) | 42 (51.2%) |
| OR (95% CI) | 1.00 | 2. 54 (1. 13 - 5.72) | 1.00 | 0. 71 (0.39 - 1.31) |
| p-value |
| 0.035 |
| 0.34 |
| Gender | ||||
| male | 102 (76.7%) | 31 (23.3%) | 59 (44.4%) | 74 (55.6%) |
| vemale | 37 (92.5%) | 3 (7.5%) | 20 (50.0%) | 20 (50.0%) |
| OR (95% CI) | 1.00 | 3.75 (1.08 - 12.99) | 1.00 | 1.26 (0.62 - 2.57) |
| p-value |
| 0.047 |
| 0.64 |
| Smoking status | ||||
| yeas | 87 (77.7%) | 25 (22.3%) | 52 (46.8%) | 59 (53.2%) |
| no | 44 (84.6%) | 8 (15.4%) | 23 (44.2%) | 29 (55.8%) |
| OR (95% CI), | 1.00 | 1.50 (0.62 - 3.62) | 1.00 | 1.05 (0.54 - 2.05) |
| p-value |
| 0.36 |
| 0.98 |
| Stage | ||||
| I-II | 87 (82.1%) | 19 (17.9%) | 53 (50.0%) | 53 (50.0%) |
| III-IV | 52 (77.6%) | 15 (22.4%) | 26 (38.8%) | 41 (61.2%) |
| OR (95% CI), | 1.00 | 1.43 (0.66 - 3.09) | 1.00 | 0.69 (0.37 - 1.30) |
| p-value |
| 0.36 |
| 0.25 |